GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEY) » Definitions » Short Ratio

Ipsen (IPSEY) Short Ratio


View and export this data going back to 2007. Start your Free Trial

What is Ipsen Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Ipsen Business Description

Traded in Other Exchanges
Address
65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Ipsen Headlines

From GuruFocus

Full Year 2022 Ipsen SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2021 Ipsen SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2021 Ipsen SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2021 Ipsen SA Corporate Sales Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Ipsen SA Corporate Sales Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2022 Ipsen SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Ipsen SA Corporate Sales Call Transcript

By GuruFocus Research 02-14-2024